Drug Shortage Report for AURO-TELMISARTAN
Report ID | 199904 |
Drug Identification Number | 02453576 |
Brand name | AURO-TELMISARTAN |
Common or Proper name | TELMISARTAN |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | TELMISARTAN |
Strength(s) | 80MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100's and 500's |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2023-07-24 |
Estimated end date | 2024-03-15 |
Actual end date | 2024-03-13 |
Shortage status | Resolved |
Updated date | 2024-03-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2024-03-14 | English | Compare |
v9 | 2024-03-13 | French | Compare |
v8 | 2024-03-13 | English | Compare |
v7 | 2024-02-26 | French | Compare |
v6 | 2024-02-26 | English | Compare |
v5 | 2024-01-29 | French | Compare |
v4 | 2024-01-29 | English | Compare |
v3 | 2023-07-25 | English | Compare |
v2 | 2023-07-24 | French | Compare |
v1 | 2023-07-24 | English | Compare |
Showing 1 to 10 of 10